Therapy-Related Myelodysplastic Syndrome Active Not Recruiting Phase 2 Trials for Clofarabine (DB00631)

IndicationStatusPhase
DBCOND0079186 (Therapy-Related Myelodysplastic Syndrome)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03096782Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaTreatment
NCT01885689Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic LeukemiaTreatment